United States · 
What does SynBioVen invest in?
SynBioVen invests most often at Seed and Series A (100% of the rounds on record), in sectors such as Synthetic Biology.
SynBioVen highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Seed and Series A: 100% of its rounds
What they do
SynBioVen is a new investment vehicle launched in early 2022 focused on supporting the next generation of synthetic biology scientists, founders and start-ups.From their own website
- Type
- VC firm
- Cheque size
- Not stated
- Stages
- Pre-seedSeed
- Sectors
- Synthetic Biology
- Based in
- London, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2026
1 round
- May
- 2024
1 round
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
3 of 7 we have independently watched raise
EdenBioMultusResurrectbioChainBiotechLondon BiofoundryScindo-v2SynbiCITE
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.